UK rolls out Oxford Uni/AZ COVID-19 shot as cases soarThe first people are receiving the COVID-19 vaccine from Oxford University and AstraZeneca in the UK, as prime Share XUK rolls out Oxford Uni/AZ COVID-19 shot as cases soarhttps://pharmaphorum.com/news/uk-rolls-out-oxford-uni-az-covid-19-shot-as-cases-soar/
UK prepares for decision on AZ/Oxford vaccine as COVID cases soarThe UK’s COVID-19 vaccination programme could get a speed boost, with the country’s drugs regulator expected to make Share XUK prepares for decision on AZ/Oxford vaccine as COVID cases soarhttps://pharmaphorum.com/news/uk-prepares-for-decision-on-az-oxford-shot-as-covid-cases-soar/
‘Highly likely’ BioNTech vaccine will work against new strain, says CEOBioNTech CEO Ugur Sahin has said that it is “highly likely” the company’s COVID-19 vaccine will work against Share X‘Highly likely’ BioNTech vaccine will work against new strain, says CEOhttps://pharmaphorum.com/news/highly-likely-biontech-vaccine-will-work-against-new-strain-says-ceo/
Moderna and BioNTech – who are they?Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA Share XModerna and BioNTech – who are they?https://pharmaphorum.com/views-and-analysis/moderna-and-biontech-who-are-they/
NHS pilots virtual assistant for flu jab bookingsMore than 1,000 NHS patients have booked flu vaccinations using a virtual assistant as part of a pilot Share XNHS pilots virtual assistant for flu jab bookingshttps://pharmaphorum.com/news/nhs-pilots-virtual-assistant/
FDA aims for fast approval of Moderna’s COVID-19 shot after panel voteThe FDA is looking to quickly approve Moderna’s COVID-19 vaccine after it was unanimously backed by a panel Share XFDA aims for fast approval of Moderna’s COVID-19 shot after panel votehttps://pharmaphorum.com/news/fda-aims-for-fast-approval-of-modernas-covid-19-shot-after-panel-vote/
Trials of Valneva COVID-19 vaccine begin in UKTrials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the Share XTrials of Valneva COVID-19 vaccine begin in UKhttps://pharmaphorum.com/news/trials-of-fifth-covid-19-vaccine-begin-in-uk/
Minervax raises €47.4m in Series B funding round for GBS shotDenmark’s MinervaX has raised €47.4 million (around $56 million) in a Series B funding round to take its Share XMinervax raises €47.4m in Series B funding round for GBS shothttps://pharmaphorum.com/news/minervax-raises-e47-4m-in-series-b-funding-round-for-gbs-shot/
Family doctors begin COVID-19 immunisation drive in UKThe roll-out of the biggest vaccination programme in the history of the UK’s NHS is gathering pace, as Share XFamily doctors begin COVID-19 immunisation drive in UKhttps://pharmaphorum.com/news/family-doctors-begin-covid-19-immunisation-drive-in-uk/
